Literature DB >> 9646446

In vivo functions of the auxiliary genes and regulatory elements of feline immunodeficiency virus.

Y Inoshima1, T Miyazawa, T Mikami.   

Abstract

Feline immunodeficiency virus (FIV) is a widespread lentivirus of domestic cats that causes an acquired immunodeficiency syndrome (AIDS)-like disease similar to human AIDS caused by human immunodeficiency virus. FIV has a complex genome structure including structural, enzymatic and auxiliary genes and regulatory elements. In this article, we review the in vivo roles of some of these FIV auxiliary genes and regulatory elements, especially focusing on the dUTPase, vif, and ORF-A genes and AP-1 binding site in the enhancer region of the long terminal repeat, by comparison with those of other non-primate lentiviruses. These genes and elements are considered to be important for viral replication, immunological response and pathogenesis in cats.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9646446     DOI: 10.1016/s0378-1135(98)00157-6

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  4 in total

Review 1.  Going wild: lessons from naturally occurring T-lymphotropic lentiviruses.

Authors:  Sue VandeWoude; Cristian Apetrei
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

2.  Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses.

Authors:  L Bigornia; K M Lockridge; E E Sparger
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 3.  Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.

Authors:  Simon Henriet; Gaëlle Mercenne; Serena Bernacchi; Jean-Christophe Paillart; Roland Marquet
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

4.  Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential.

Authors:  Carmen Ledesma-Feliciano; Sarah Hagen; Ryan Troyer; Xin Zheng; Esther Musselman; Dragana Slavkovic Lukic; Ann-Mareen Franke; Daniel Maeda; Jörg Zielonka; Carsten Münk; Guochao Wei; Sue VandeWoude; Martin Löchelt
Journal:  Retrovirology       Date:  2018-05-16       Impact factor: 4.602

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.